OR WAIT null SECS
May 02, 2016
Policies for patient access to life-saving therapies must keep pace with biomedical innovation.
April 29, 2016
Immuno-oncology drugs are demonstrating patient benefits, but growing resistance to the high cost has implications for patients, market access, and manufacturers.
April 13, 2016
By focusing on laying strong technology foundations, pharmaceutical businesses can make informed decisions, equip themselves with the capabilities to eliminate threats, and future-proof operations.
April 01, 2016
At DCAT 2016, IMS Health economist Graham Lewis noted that pharma is reliving trends last seen in the 1980s. Despite value-based medicine, he said, the blockbuster model is alive and well.
March 24, 2016
Collaboration will provide for unified development and manufacture of antibody drug conjugates.
March 22, 2016
Generic drugs, market access, and foreign manufacturing are conference topics at CPhI Japan 2016.
February 16, 2016
Wyeth reaches agreement in principle to resolve Medicaid drug rebate claims for 2001-2006 period for Protonix.
February 09, 2016
Pfizer names executive leadership team for combined organization upon close of proposed Allergan transaction.
February 02, 2016
Suppliers must develop new technologies to drive the bio/pharma innovation engine.
January 02, 2016
Infrastructure and payer decisions will determine drug choices in emerging and developed regions.